For example, genome-wide expression profiling following JQ1 treatment identified IL7R, along with MYC, to be among the most down-regulated genes, and early studies correlated BRD4 inhibition with decreased IL7R expression and loss of BRD4 loading at the IL7R promoter across different cancer subtypes (60). This evidence concerns the gene BRD4 and cancer.